ATOS - .655 Pre-market now at .75/.7545 Atossa Genetics Receives Positive Interim Review From Independent Safety Committee in Phase 1 Endoxifen Dose Escalation Study http://stockcharts.com/c-sc/sc?s=ATOS&p=D&b=5&g=0&i=t95225214685&r=1492692471079 http://stockcharts.com/c-sc/sc?s=ATOS&p=W&b=5&g=0&i=t82657855981&r=1492692507978